AMOTL2: A key regulator of mechanotransduction in development, vascular disease and cancer
Cells & Development · 2026-11 · 204119
DOI: 10.1016/j.cdev.2026.204119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells & Development, 2026-11. Verfasst von Pedro Fonseca und 2 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Cancer Society, Swedish Research Council, The Swedish Heart Lung Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Swedish Cancer Society
- Swedish Research Council
- The Swedish Heart Lung Foundation
Zitieren
APA
Fonseca, P., Zhang, Y., & Holmgren, L. (2026). AMOTL2: A key regulator of mechanotransduction in development, vascular disease and cancer. Cells & Development, 204119. https://doi.org/10.1016/j.cdev.2026.204119
Vancouver
Fonseca P, Zhang Y, Holmgren L. AMOTL2: A key regulator of mechanotransduction in development, vascular disease and cancer. Cells & Development. 2026:204119. doi:10.1016/j.cdev.2026.204119
BibTeX
@article{Fonseca2026,
author = {Fonseca, Pedro and Zhang, Yuanyuan and Holmgren, Lars},
title = {AMOTL2: A key regulator of mechanotransduction in development, vascular disease and cancer},
journal = {Cells & Development},
year = {2026},
pages = {204119},
doi = {10.1016/j.cdev.2026.204119}
}
EUVIMED